Entera Bio raises $275m for Phase III osteoporosis drug trial
Israeli drug development company Entera Bio (Nasdaq: ENTX) has announced a $275 million private placement. Prior to the announcement ...
Tuesday, July 28, 2026
Tag: osteoporosis
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.